Quick Answer
PLUS THERAPEUTICS, INC. reported Revenue (ASC 606) of $3.67 million for fiscal year 2018.
PLUS THERAPEUTICS, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2018 | $3.67M | +36.5% |
| 2017 | $2.69M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| March 31, 2019 | $703.0K | -3.8% | -18.1% |
| September 30, 2018 | $858.0K | +83.7% | +17.4% |
| March 31, 2018 | $731.0K | — | +56.5% |
| September 30, 2017 | $467.0K | — | — |
- PLUS THERAPEUTICS, INC. showed an increase of +36.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2018 period, PLUS THERAPEUTICS, INC.’s revenue (asc 606) has grown by 36.5% (from $2.69 million to $3.67 million).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 29, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: